Growth Metrics

Uxin (UXIN) EBIT (2018 - 2025)

Historic EBIT for Uxin (UXIN) over the last 8 years, with Q3 2025 value amounting to -$36469.0.

  • Uxin's EBIT rose 564.05% to -$36469.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$21.0 million, marking a year-over-year increase of 10000.0%. This contributed to the annual value of -$39.0 million for FY2024, which is N/A changed from last year.
  • Uxin's EBIT amounted to -$36469.0 in Q3 2025, which was up 564.05% from -$6.0 million recorded in Q2 2025.
  • Uxin's 5-year EBIT high stood at $133.4 billion for Q1 2021, and its period low was -$23900000.0 billion during Q2 2024.
  • Its 5-year average for EBIT is -$1257880.6 billion, with a median of -$14952.0 in 2022.
  • As far as peak fluctuations go, Uxin's EBIT surged by 474751.13% in 2021, and later plummeted by 2.7427128758319935e19% in 2024.
  • Over the past 5 years, Uxin's EBIT (Quarter) stood at $120.0 billion in 2021, then crashed by 100.0% to -$270986.0 in 2022, then surged by 73.03% to -$73078.0 in 2023, then crashed by 13656.53% to -$10.1 million in 2024, then skyrocketed by 99.64% to -$36469.0 in 2025.
  • Its EBIT stands at -$36469.0 for Q3 2025, versus -$6.0 million for Q2 2025 and -$4.9 million for Q1 2025.